Stock ENFN ENFUSION, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Enfusion, Inc.

Equities

ENFN

US2928121043

Market Closed - Nyse
Other stock markets
 16:00:02 2024-06-27 EDT 		5-day change 1st Jan Change
8.59 USD +2.26% Intraday chart for Enfusion, Inc. +5.27% -11.44%
06-12 Transcript : Enfusion, Inc. Presents at Morgan Stanley US Financials, Payments & CRE Conference 2024, Jun-12-2024 08:00 AM
05-22 Enfusion Insider Sold Shares Worth $325,263, According to a Recent SEC Filing MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : Enfusion, Inc. Presents at Morgan Stanley US Financials, Payments & CRE Conference 2024, Jun-12-2024 08:00 AM
Enfusion : William Blair 44th Annual Growth Stock Presentation
PU
Enfusion To Present at Upcoming Investor Events
BU
Enfusion Insider Sold Shares Worth $325,263, According to a Recent SEC Filing
MT
Enfusion, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Enfusion Shares Fall Despite Higher Q1 Results
MT
Transcript : Enfusion, Inc., Q1 2024 Earnings Call, May 09, 2024
Enfusion Announces First Quarter 2024 Results
BU
Enfusion Announces Date of First Quarter 2024 Results
BU
Matt Campobasso: "The Legal Team Has To Be Able To See Around Corners"
AQ
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Enfusion, Inc. - ENFN
PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Enfusion, Inc. - ENFN
PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Enfusion, Inc. - ENFN
PR
Kayne Anderson Strengthens Investment Operations After Successful Platform Migration to Enfusion
BU
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Enfusion, Inc. - ENFN
PR
Enfusion Shares Slip After Short-Seller Spruce Point Warns of 'Financial Restatement Risk'
MT
BofA Securities Adjusts Price Target on Enfusion to $9 From $8, Maintains Underperform Rating
MT
Enfusion, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Sector Update: Tech Stocks Advance Pre-Bell Tuesday
MT
Enfusion, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ENFN Stock
  4. News Enfusion, Inc.